HC Wainwright & Co. Maintains Buy on Inozyme Pharma, Lowers Price Target to $20
HC Wainwright & Co. analyst Edward White maintains Inozyme Pharma (NASDAQ:INZY) with a Buy and lowers the price target from $33 to $20.
60 Biggest Movers From Yesterday
Gainers
Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
Mid-Afternoon Market Update: Nasdaq Down 200 Points; United Airlines Shares Jump
U.S. stocks turned lower toward the end of trading, with the Nasdaq dropping 200 points on Thursday.
Mid-Day Market Update: Nasdaq Turns Negative; US Weekly Jobless Claims Edge Lower
U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping around 50 points on Thursday.
30 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Swvl Holdings Corp. (NASDAQ: SWVL) shares gained 34.3% to $5.72.
Alpha Tau Medical Ltd. (NASDAQ: DRTS) shares climbed 19.3% to $10.62.
Mid-Morning Market Update: Markets Open Higher; Tesla Beats Q1 Estimates
U.S. stocks traded higher this morning, after Tesla Inc (NASDAQ: TSLA) reported better-than-expected quarterly results.
Executives Buy Around $5M Of 3 Penny Stocks
US stocks closed mixed on Wednesday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Inozyme Pharma Announces $73M Underwritten Offering Priced At-the-Market
Inozyme Pharma, Inc. (NASDAQ:INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today announced the pricing of an underwritten